Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DTC Principle Statements From Drug Companies Urged By Lilly's Taurel

Executive Summary

Pharmaceutical companies should develop direct-to-consumer advertising principles, outgoing Pharmaceutical Research & Manufacturers of America Chairman Sidney Taurel declared in his May 11 address to the association annual meeting.

You may also be interested in...



DTC Principles Still On PhRMA’s Agenda; J&J Tries Leading By Example

Pharmaceutical companies should acknowledge that direct-to-consumer advertising may "inadvertently" minimize risk information, incoming Pharmaceutical Research & Manufacturers of America Chairman William Weldon (J&J) told the association's annual meeting in Washington, D.C. March 18

DTC Principles Still On PhRMA’s Agenda; J&J Tries Leading By Example

Pharmaceutical companies should acknowledge that direct-to-consumer advertising may "inadvertently" minimize risk information, incoming Pharmaceutical Research & Manufacturers of America Chairman William Weldon (J&J) told the association's annual meeting in Washington, D.C. March 18

DTC Guidelines Coming Soon From PhRMA; Code Will Stress “Balanced” Ads

PhRMA is developing guidelines on direct-to-consumer advertising, incoming Chairman Miles White (Abbott) said during the trade association's annual meeting in Palm Beach, Fla. April 3

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS032174

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel